Fruzzetti F

No ORCID on file · 2 papers in corpus

review 2024

A review of the pharmacology, clinical outcomes, and real-world effectiveness, safety, and non-contraceptive effects of NOMAC/E2

European journal of obstetrics & gynecology and reproductive biology: X ·doi:10.1016/j.eurox.2024.100283

Selecting an appropriate oral contraceptive can be challenging for healthcare professionals due to the abundance of marketed contraceptive options with different clinical and real-world effectiveness and safety profiles. Nomegestrol acetate…

other 2021

Characterization of a novel mutation V136L in bone morphogenetic protein 15 identified in a woman affected by POI

Journal of ovarian research ·doi:10.1186/s13048-021-00836-7

BACKGROUND: Premature ovarian insufficiency (POI) is an ovarian defect characterized by primary or secondary amenorrhea, hypergonadotropism and hypoestrogenism which occurs before the age of 40 years with a major genetic component. In this …